Bio­haven CEO Vlad Coric fi­nal­ly had the at­ten­tion of the FDA, and most im­por­tant­ly, Com­mis­sion­er Mar­ty Makary.

In late April, af­ter the com­pa­ny’s spin­ocere­bel­lar atax­ia …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.